Rising Vector Demand Bottlenecks in lentiviral vector supply are driving demand for scalable, dependable manufacturing. iVexSol positions itself with an end-to-end solution to shorten development timelines and secure supply, appealing to CGT programs facing wait times and raw material shortages.

End-to-End Capacity Our Intelligent Vector Solutions can manufacture any lentiviral vector at any scale, offering a single vendor from development through manufacturing to delivery, enabling faster timelines and reduced risk for clients.

Growth Momentum Recent leadership appointments and significant funding indicate an accelerating growth trajectory and readiness to engage in larger partnerships, co-development deals, or exclusive supply arrangements with expanding gene therapy programs.

Local Biotech Hub Based in Lexington, MA, iVexSol sits in the Boston biotech ecosystem with access to nearby talent, CROs/CMOs, and potential collaborations with regional universities and startups pursuing lentiviral vector programs.

Target Sales Plays Ideal customers include early to mid-stage gene therapy developers needing reliable lentiviral vector supply and scalable manufacturing capacity; sales angles include scalable capacity agreements, process development and tech transfer, and supply chain risk mitigation with a single partner.